Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 29-Apr-24 4:10 PM View:  | Burrell Terry-Ann Chief Financial Officer | Beam Therapeutics Inc. (BEAM) | 26-Apr-24 | Grant | 12,500 | -- | -- | 18% 70.14K to 82.64K | |
| 03-Apr-24 7:43 PM View: | Simon Amy Chief Medical Officer | Beam Therapeutics Inc. (BEAM) | 02-Apr-24 | Sale (Planned) | 16,530 | $30.54 | $504,851.00 | (19%) 86.59K to 70.06K | |
| 03-Apr-24 7:36 PM View: | Evans John M. CEO Director | Beam Therapeutics Inc. (BEAM) | 01-Apr-24 | Sale (Planned) | 18,102 | $32.13 | $581,617.00 | (2%) 1.18M to 1.16M | |
| 03-Apr-24 7:40 PM View: | Bellon Christine Chief Legal Officer | Beam Therapeutics Inc. (BEAM) | 01-Apr-24 | Sale (Planned) | 3,401 | $32.12 | $109,240.00 | (3%) 108.0K to 104.59K | |
| 03-Apr-24 7:39 PM View: | Burrell Terry-Ann Chief Financial Officer | Beam Therapeutics Inc. (BEAM) | 01-Apr-24 | Sale (Planned) | 5,446 | $32.12 | $174,926.00 | (7%) 75.58K to 70.14K | |
| 03-Apr-24 7:43 PM View: | Simon Amy Chief Medical Officer | Beam Therapeutics Inc. (BEAM) | 01-Apr-24 | Sale (Planned) | 7,157 | $32.13 | $229,954.00 | (8%) 93.75K to 86.59K | |
| 03-Apr-24 7:33 PM View: | Ciaramella Giuseppe President | Beam Therapeutics Inc. (BEAM) | 01-Apr-24 | Sale (Planned) | 4,534 | $32.12 | $145,632.00 | (3%) 174.15K to 169.62K | |
| 02-Apr-24 4:10 PM View: | Burrell Terry-Ann Chief Financial Officer | Beam Therapeutics Inc. (BEAM) | 31-Mar-24 | Grant | 27,500 | -- | -- | 57% 48.08K to 75.58K | |
| 02-Apr-24 4:10 PM View: | Simon Amy Chief Medical Officer | Beam Therapeutics Inc. (BEAM) | 31-Mar-24 | Grant | 27,500 | -- | -- | 42% 66.25K to 93.75K | |
| 02-Apr-24 4:10 PM View: | Ciaramella Giuseppe President | Beam Therapeutics Inc. (BEAM) | 31-Mar-24 | Grant | 35,000 | -- | -- | 25% 139.15K to 174.15K | |
| 01-Apr-24 4:10 PM View: | Evans John M. CEO Director | Beam Therapeutics Inc. (BEAM) | 31-Mar-24 | Grant | 77,500 | -- | -- | 7% 1.1M to 1.18M | |
| 02-Apr-24 4:10 PM View: | Bellon Christine Chief Legal Officer | Beam Therapeutics Inc. (BEAM) | 31-Mar-24 | Grant | 27,500 | -- | -- | 34% 80.5K to 108.0K | |
| 01-Apr-24 4:10 PM View: | Evans John M. CEO Director | Beam Therapeutics Inc. (BEAM) | 28-Mar-24 | Sale (Planned) | 60,000 | $33.86 | $2,031,400.00 | (5%) 1.16M to 1.1M | |
| 15-Feb-24 2:34 PM View: | Fmr Corp | Beam Therapeutics Inc. (BEAM) | 14-Feb-24 | Sale | 900,000 | $30.55 | $27,496,900.00 | (18%) 4.91M to 4.01M | |
| 15-Feb-24 2:34 PM View: | Fmr Corp | Beam Therapeutics Inc. (BEAM) | 13-Feb-24 | Sale | 1,565 | $30.76 | $48,138.90 | (< 1%) 4.91M to 4.91M | |
| 02-Feb-24 4:05 PM View: | Evans John M. CEO Director | Beam Therapeutics Inc. (BEAM) | 31-Jan-24 | Sale (Planned) | 60,000 | $25.33 | $1,519,800.00 | (5%) 1.22M to 1.16M | |
| 05-Jan-24 4:30 PM View: | Bellon Christine Chief Legal Officer | Beam Therapeutics Inc. (BEAM) | 03-Jan-24 | Sale (Planned) | 1,907 | $26.42 | $50,382.90 | (2%) 82.4K to 80.5K | |
| 27-Dec-23 10:56 AM View: | Fmr Corp 10% Owner | Beam Therapeutics Inc. (BEAM) | 22-Dec-23 | Disposition (other) | 29,549 | -- | -- | (< 1%) 4.94M to 4.91M | |
| 22-Nov-23 4:05 PM View: | Bellon Christine Chief Legal Officer | Beam Therapeutics Inc. (BEAM) | 20-Nov-23 | Planned Option Sale | 10,000 | $30.50 | $305,000.00 | (11%) 92.4K to 82.4K | |
| 22-Nov-23 4:05 PM View: | Bellon Christine Chief Legal Officer | Beam Therapeutics Inc. (BEAM) | 20-Nov-23 | Option Exercise | 10,000 | $7.22 | $72,200.00 | 12% 82.4K to 92.4K | |
| 01-Nov-23 4:30 PM View: | Simon Amy Chief Medical Officer | Beam Therapeutics Inc. (BEAM) | 30-Oct-23 | Sale (Planned) | 3,448 | $18.70 | $64,477.60 | (5%) 68.92K to 65.47K | |
| 24-Oct-23 4:05 PM View: | Ciaramella Giuseppe President and CSO | Beam Therapeutics Inc. (BEAM) | 20-Oct-23 | Option Exercise | 90,900 | $0.67 | $60,903.00 | 188% 48.25K to 139.15K | |
| 04-Oct-23 4:30 PM View: | Bellon Christine Chief Legal Officer | Beam Therapeutics Inc. (BEAM) | 02-Oct-23 | Sale (Planned) | 388 | $22.85 | $8,865.80 | (< 1%) 82.79K to 82.4K | |
| 25-Jul-23 6:36 PM View: | Ciaramella Giuseppe President and CSO | Beam Therapeutics Inc. (BEAM) | 24-Jul-23 | Sale (Planned) | 1,206 | $32.01 | $38,604.10 | (2%) 49.46K to 48.25K | |
| 25-Jul-23 6:36 PM View: | Ciaramella Giuseppe President and CSO | Beam Therapeutics Inc. (BEAM) | 24-Jul-23 | Option Exercise | 1,206 | $7.22 | $8,707.32 | 2% 48.25K to 49.46K | |
| 25-Jul-23 6:36 PM View: | Ciaramella Giuseppe President and CSO | Beam Therapeutics Inc. (BEAM) | 21-Jul-23 | Option Exercise | 91,284 | $7.22 | $659,070.00 | 81% 112.29K to 203.57K | |
| 25-Jul-23 6:36 PM View: | Ciaramella Giuseppe President and CSO | Beam Therapeutics Inc. (BEAM) | 21-Jul-23 | Planned Option Sale | 92,490 | $32.06 | $2,965,230.00 | (45%) 203.57K to 111.08K | |
| 25-Jul-23 6:36 PM View: | Ciaramella Giuseppe President and CSO | Beam Therapeutics Inc. (BEAM) | 21-Jul-23 | Sale (Planned) | 62,834 | $32.06 | $2,014,460.00 | (57%) 111.08K to 48.25K | |
| 09-Aug-23 4:08 PM View: | Simon Amy Chief Medical Officer | Beam Therapeutics Inc. (BEAM) | 10-Jul-23 | Sale (Planned) | 391 | $30.48 | $11,917.70 | (< 1%) 69.31K to 68.92K | |
| 05-Apr-23 8:30 PM View: | Ciaramella Giuseppe President & CSO | Beam Therapeutics Inc. (BEAM) | 04-Apr-23 | Sale (Planned) | 1,754 | $29.09 | $51,028.90 | (2%) 114.04K to 112.29K | |
| 05-Apr-23 8:30 PM View: | Bellon Christine Chief Legal Officer | Beam Therapeutics Inc. (BEAM) | 04-Apr-23 | Sale (Planned) | 1,161 | $29.09 | $33,777.10 | (1%) 83.95K to 82.79K | |
| 05-Apr-23 8:30 PM View: | Simon Amy Chief Medical Officer | Beam Therapeutics Inc. (BEAM) | 04-Apr-23 | Sale (Planned) | 11,654 | $29.70 | $346,115.00 | (14%) 80.96K to 69.31K | |
| 05-Apr-23 8:30 PM View: | Evans John M. CEO Director | Beam Therapeutics Inc. (BEAM) | 04-Apr-23 | Sale (Planned) | 6,493 | $29.09 | $188,904.00 | (< 1%) 1.23M to 1.22M | |
| 05-Apr-23 8:30 PM View: | Burrell Terry-Ann Chief Financial Officer | Beam Therapeutics Inc. (BEAM) | 04-Apr-23 | Sale (Planned) | 2,186 | $29.09 | $63,597.50 | (4%) 49.3K to 47.12K | |
| 05-Apr-23 8:30 PM View: | Simon Amy Chief Medical Officer | Beam Therapeutics Inc. (BEAM) | 03-Apr-23 | Sale (Planned) | 4,445 | $30.31 | $134,728.00 | (5%) 85.41K to 80.96K | |
| 05-Apr-23 8:30 PM View: | Evans John M. CEO Director | Beam Therapeutics Inc. (BEAM) | 03-Apr-23 | Sale (Planned) | 5,161 | $30.31 | $156,430.00 | (< 1%) 1.23M to 1.23M | |
| 05-Apr-23 8:30 PM View: | Burrell Terry-Ann Chief Financial Officer | Beam Therapeutics Inc. (BEAM) | 03-Apr-23 | Sale (Planned) | 2,454 | $30.31 | $74,380.70 | (5%) 51.76K to 49.3K | |
| 05-Apr-23 8:30 PM View: | Ciaramella Giuseppe President & CSO | Beam Therapeutics Inc. (BEAM) | 03-Apr-23 | Sale (Planned) | 1,918 | $30.31 | $58,134.60 | (2%) 115.96K to 114.04K | |
| 05-Apr-23 8:30 PM View: | Bellon Christine Chief Legal Officer | Beam Therapeutics Inc. (BEAM) | 03-Apr-23 | Sale (Planned) | 931 | $30.31 | $28,218.60 | (1%) 84.88K to 83.95K | |
| 31-Mar-23 7:48 PM View: | Evans John M. CEO Director | Beam Therapeutics Inc. (BEAM) | 31-Mar-23 | Grant | 56,250 | -- | -- | 5% 1.16M to 1.22M | |
| 31-Mar-23 7:51 PM View: | Bellon Christine Chief Legal Officer | Beam Therapeutics Inc. (BEAM) | 31-Mar-23 | Grant | 17,500 | -- | -- | 26% 67.38K to 84.88K | |
| 31-Mar-23 7:49 PM View: | Ciaramella Giuseppe President & CSO | Beam Therapeutics Inc. (BEAM) | 31-Mar-23 | Grant | 20,000 | -- | -- | 21% 95.96K to 115.96K | |
| 31-Mar-23 7:46 PM View: | Burrell Terry-Ann Chief Financial Officer | Beam Therapeutics Inc. (BEAM) | 31-Mar-23 | Grant | 20,000 | -- | -- | 64% 31.28K to 51.28K | |
| 31-Mar-23 7:47 PM View: | Simon Amy Chief Medical Officer | Beam Therapeutics Inc. (BEAM) | 31-Mar-23 | Grant | 20,000 | -- | -- | 31% 65.13K to 85.13K | |
| 31-Mar-23 7:48 PM View: | Evans John M. CEO Director | Beam Therapeutics Inc. (BEAM) | 31-Mar-23 | Option Exercise | 13,850 | $7.22 | $99,997.00 | 1% 1.22M to 1.23M | |
| 31-Mar-23 7:51 PM View: | Bellon Christine Chief Legal Officer | Beam Therapeutics Inc. (BEAM) | 30-Mar-23 | Option Exercise | 8,941 | $7.22 | $64,554.00 | 15% 58.44K to 67.38K | |
| 31-Mar-23 7:48 PM View: | Evans John M. CEO Director | Beam Therapeutics Inc. (BEAM) | 06-Mar-23 | Acquisition (small) | 225 | -- | -- | < 1% 1.16M to 1.16M | |
| 30-Jan-23 4:05 PM View: | Burrell Terry-Ann Chief Financial Officer | Beam Therapeutics Inc. (BEAM) | 27-Jan-23 | Option Exercise | 36,152 | $13.68 | $494,559.00 | 116% 31.28K to 67.43K | |
| 30-Jan-23 4:05 PM View: | Burrell Terry-Ann Chief Financial Officer | Beam Therapeutics Inc. (BEAM) | 27-Jan-23 | Planned Option Sale | 36,152 | $45.08 | $1,629,750.00 | (54%) 67.43K to 31.28K | |
| 30-Jan-23 4:05 PM View: | Burrell Terry-Ann Chief Financial Officer | Beam Therapeutics Inc. (BEAM) | 26-Jan-23 | Option Exercise | 1,102 | $13.68 | $15,075.40 | 4% 31.28K to 32.38K |
